![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 12, 7099-7106, March 20, 1998
From INSERM U151, Institut Louis Bugnard, IFR 31, CHU Rangueil,
31403 Toulouse Cedex 04, France and § Institut Cochin de
Génétique Moléculaire, 75014 Paris, France
We have previously reported in Chinese hamster
ovary (CHO) cells expressing sst2 that activation of the sst2
somatostatin receptor inhibits insulin-induced cell proliferation by a
mechanism involving stimulation of a tyrosine phosphatase activity.
Here we show that the tyrosine phosphatase SHP-1 was associated with the insulin receptor (IR) at the basal level. Activation of IR by
insulin resulted in a rapid and transient increase of tyrosine phosphorylation of IR, its substrates IRS-1 and Shc, and also of SHP-1.
This was then followed by a rapid dephosphorylation of these molecules,
which was related to the insulin-induced increase of SHP-1 association
to IR and of SHP-1 activity. On the other hand, addition to insulin of
the somatostatin analogue, RC160, resulted in a higher and faster
increase of SHP-1 association to IR directly correlated with an
inhibition of phosphorylation of IR and its substrates, IRS-1 and Shc.
RC160 also induced a higher and more sustained increase in SHP-1
activity. Furthermore, RC160 completely suppressed the effect of
insulin on SHP-1 phosphorylation. Finally, in CHO cells coexpressing
sst2 and a catalytically inactive mutant SHP-1, insulin as well as
RC160 could no longer stimulate SHP-1 activity. Overexpression of the
SHP-1 mutant prevented the insulin-induced signaling to be terminated
by dephosphorylation of IR, suppressed the inhibitory effect of RC160
on insulin-induced IR phosphorylation, and abolished the cell
proliferation modulation by insulin and RC160. Our results suggest that
SHP-1 plays a role in negatively modulating insulin signaling by
association with IR. Furthermore, somatostatin inhibits the
insulin-induced mitogenic signal by accelerating and amplifying the
effect of SHP-1 on the termination of the insulin signaling
pathway.
This article has been cited by other articles:
![]() |
J. Gillibert-Duplantier, V. Neaud, J.-F. Blanc, P. Bioulac-Sage, and J. Rosenbaum Thrombin inhibits migration of human hepatic myofibroblasts Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G128 - G136. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cordelier, J.-P. Esteve, S. Najib, L. Moroder, N. Vaysse, L. Pradayrol, C. Susini, and L. Buscail Regulation of Neuronal Nitric-oxide Synthase Activity by Somatostatin Analogs following SST5 Somatostatin Receptor Activation J. Biol. Chem., July 14, 2006; 281(28): 19156 - 19171. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tagliati, M. C. Zatelli, A. Bottoni, D. Piccin, A. Luchin, M. D. Culler, and E. C. degli Uberti Role of Complex Cyclin D1/Cdk4 in Somatostatin Subtype 2 Receptor-Mediated Inhibition of Cell Proliferation of a Medullary Thyroid Carcinoma Cell Line in Vitro Endocrinology, July 1, 2006; 147(7): 3530 - 3538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Theodoropoulou, J. Zhang, S. Laupheimer, M. Paez-Pereda, C. Erneux, T. Florio, U. Pagotto, and G. K. Stalla Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression Cancer Res., February 1, 2006; 66(3): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Zatelli, D. Piccin, F. Tagliati, A. Bottoni, A. Luchin, and E. C. degli Uberti Src Homology-2-Containing Protein Tyrosine Phosphatase-1 Restrains Cell Proliferation in Human Medullary Thyroid Carcinoma Endocrinology, June 1, 2005; 146(6): 2692 - 2698. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MASSA, F. BARBIERI, C. AIELLO, R. IULIANO, S. ARENA, A. PATTAROZZI, A. CORSARO, V. VILLA, A. FUSCO, G. ZONA, et al. The Phosphotyrosine Phosphatase {eta} Mediates Somatostatin Inhibition of Glioma Proliferation via the Dephosphorylation of ERK1/2 Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 264 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Massa, F. Barbieri, C. Aiello, S. Arena, A. Pattarozzi, P. Pirani, A. Corsaro, R. Iuliano, A. Fusco, G. Zona, et al. The Expression of the Phosphotyrosine Phosphatase DEP-1/PTP{eta} Dictates the Responsivity of Glioma Cells to Somatostatin Inhibition of Cell Proliferation J. Biol. Chem., July 9, 2004; 279(28): 29004 - 29012. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Min, T.-X. Cui, Y. Yahata, K. Yamasaki, T. Shiuchi, H.-W. Liu, R. Chen, J.-M. Li, M. Okumura, T. Jinno, et al. Regulation of Collagen Synthesis in Mouse Skin Fibroblasts by Distinct Angiotensin II Receptor Subtypes Endocrinology, January 1, 2004; 145(1): 253 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lahlou, N. Saint-Laurent, J.-P. Esteve, A. Eychene, L. Pradayrol, S. Pyronnet, and C. Susini sst2 Somatostatin Receptor Inhibits Cell Proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 Activation J. Biol. Chem., October 10, 2003; 278(41): 39356 - 39371. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferjoux, F. Lopez, J.-P. Esteve, A. Ferrand, E. Vivier, F. Vely, N. Saint-Laurent, L. Pradayrol, L. Buscail, and C. Susini Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell Proliferation Mol. Biol. Cell, September 1, 2003; 14(9): 3911 - 3928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hortala, G. Ferjoux, A. Estival, C. Bertrand, S. Schulz, L. Pradayrol, C. Susini, and F. Clemente Inhibitory Role of the Somatostatin Receptor SST2 on the Intracrine-regulated Cell Proliferation Induced by the 210-Amino Acid Fibroblast Growth Factor-2 Isoform: IMPLICATION OF JAK2 J. Biol. Chem., May 30, 2003; 278(23): 20574 - 20581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guillermet, N. Saint-Laurent, P. Rochaix, O. Cuvillier, T. Levade, A. V. Schally, L. Pradayrol, L. Buscail, C. Susini, and C. Bousquet Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis PNAS, January 7, 2003; 100(1): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-X. Cui, H. Nakagami, C. Nahmias, T. Shiuchi, Y. Takeda-Matsubara, J.-M. Li, L. Wu, M. Iwai, and M. Horiuchi Angiotensin II Subtype 2 Receptor Activation Inhibits Insulin-Induced Phosphoinositide 3-Kinase and Akt and Induces Apoptosis in PC12W Cells Mol. Endocrinol., September 1, 2002; 16(9): 2113 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Zapata, R. M. Ropero, A. M. Valencia, L. Buscail, J. I. Lopez, R. M. Martin-Orozco, J. C. Prieto, J. Angulo, C. Susini, P. Lopez-Ruiz, et al. Autocrine Regulation of Human Prostate Carcinoma Cell Proliferation by Somatostatin through the Modulation of the SH2 Domain Containing Protein Tyrosine Phosphatase (SHP)-1 J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 915 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Florio, S. Arena, S. Thellung, R. Iuliano, A. Corsaro, A. Massa, A. Pattarozzi, A. Bajetto, F. Trapasso, A. Fusco, et al. The Activation of the Phosphotyrosine Phosphatase {eta} (r-PTP{eta}) Is Responsible for the Somatostatin Inhibition of PC Cl3 Thyroid Cell Proliferation Mol. Endocrinol., October 1, 2001; 15(10): 1838 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yoshida, T. Ishibashi, and M. Nishio Growth-inhibitory Effect of a Streptococcal Antitumor Glycoprotein on Human Epidermoid Carcinoma A431 Cells: Involvement of Dephosphorylation of Epidermal Growth Factor Receptor Cancer Res., August 1, 2001; 61(16): 6151 - 6157. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Charland, M.-J. Boucher, M. Houde, and N. Rivard Somatostatin Inhibits Akt Phosphorylation and Cell Cycle Entry, But Not p42/p44 Mitogen-Activated Protein (MAP) Kinase Activation in Normal and Tumoral Pancreatic Acinar Cells Endocrinology, January 1, 2001; 142(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Elbaz, K. Bedecs, M. Masson, M. Sutren, A. D. Strosberg, and C. Nahmias Functional Trans-inactivation of Insulin Receptor Kinase by Growth-Inhibitory Angiotensin II AT2 Receptor Mol. Endocrinol., June 1, 2000; 14(6): 795 - 804. [Abstract] [Full Text] |
||||
![]() |
D.-Q. Guo, L.-W. Wu, J. D. Dunbar, O. N. Ozes, L. D. Mayo, K. M. Kessler, J. A. Gustin, M. R. Baerwald, E. A. Jaffe, R. S. Warren, et al. Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation J. Biol. Chem., April 6, 2000; 275(15): 11216 - 11221. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Lee and C. H. Streuli Extracellular Matrix Selectively Modulates the Response of Mammary Epithelial Cells to Different Soluble Signaling Ligands J. Biol. Chem., August 6, 1999; 274(32): 22401 - 22408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. A. Lehtonen, L. Daviet, C. Nahmias, M. Horiuchi, and V. J. Dzau Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis Mol. Endocrinol., July 1, 1999; 13(7): 1051 - 1060. [Abstract] [Full Text] |
||||
![]() |
P. Pages, N. Benali, N. Saint-Laurent, J.-P. Esteve, A. V. Schally, J. Tkaczuk, N. Vaysse, C. Susini, and L. Buscail sst2 Somatostatin Receptor Mediates Cell Cycle Arrest and Induction of p27Kip1. EVIDENCE FOR THE ROLE OF SHP-1 J. Biol. Chem., May 21, 1999; 274(21): 15186 - 15193. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Douziech, E. Calvo, Z. Coulombe, G. Muradia, J. Bastien, R. A. Aubin, A. Lajas, and J. Morisset Inhibitory and Stimulatory Effects of Somatostatin on Two Human Pancreatic Cancer Cell Lines: A Primary Role for Tyrosine Phosphatase SHP-1 Endocrinology, February 1, 1999; 140(2): 765 - 777. [Abstract] [Full Text] |
||||
![]() |
C. J. Auernhammer, V. Chesnokova, C. Bousquet, and S. Melmed Pituitary Corticotroph SOCS-3: Novel Intracellular Regulation of Leukemia-Inhibitory Factor-Mediated Proopiomelanocortin Gene Expression and Adrenocorticotropin Secretion Mol. Endocrinol., July 1, 1998; 12(7): 954 - 961. [Abstract] [Full Text] |
||||
![]() |
E. Puente, N. Saint-Laurent, J. Torrisani, C. Furet, A. V. Schally, N. Vaysse, L. Buscail, and C. Susini Transcriptional Activation of Mouse sst2 Somatostatin Receptor Promoter by Transforming Growth Factor-beta . INVOLVEMENT OF Smad4 J. Biol. Chem., April 13, 2001; 276(16): 13461 - 13468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |